GB967133A - Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives - Google Patents
Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivativesInfo
- Publication number
- GB967133A GB967133A GB14030/62A GB1403062A GB967133A GB 967133 A GB967133 A GB 967133A GB 14030/62 A GB14030/62 A GB 14030/62A GB 1403062 A GB1403062 A GB 1403062A GB 967133 A GB967133 A GB 967133A
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- isonicotinoyl
- sulphoxylate
- leprotic
- tubercular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/86—Hydrazides; Thio or imino analogues thereof
Abstract
The sodium, calcium and magnesium salts of isonicotinoyl-hydrazine -N- methylene sulphoxylate are prepared by reacting the metal formaldehyde sulphoxylate with isonicotinic acid hydrazide.ALSO:Pharmaceutical compositions for the treatment of leprosy and tuberculosis comprise sodium formaldehyde sulphoxylate and a salt of isonicotinoyl-hydrazine-N-methylene sulphoxylate e.g. the Na, p Ca or Mg salt. They may be put up into conventional forms suitable for oral, parenteral and rectal administration e.g. a tablet, aqueous injectable solution or suppository such forms containing conventional pharmaceutical excipients.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR858382A FR1120M (en) | 1961-04-11 | 1961-04-11 | Drug combinations comprising sodium formaldehyde sulfoxylate and the sodium salt of n- (methylene sulfoxylate) isonicotinoyl hydrazide intended for the treatment of tuberculosis and leprosy. |
Publications (1)
Publication Number | Publication Date |
---|---|
GB967133A true GB967133A (en) | 1964-08-19 |
Family
ID=8752806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB14030/62A Expired GB967133A (en) | 1961-04-11 | 1962-04-11 | Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR1120M (en) |
GB (1) | GB967133A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455234A (en) * | 1994-03-16 | 1995-10-03 | Ahluwalia; Gurpreet S. | Inhibition of hair growth |
-
1961
- 1961-04-11 FR FR858382A patent/FR1120M/en not_active Expired
-
1962
- 1962-04-11 GB GB14030/62A patent/GB967133A/en not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5455234A (en) * | 1994-03-16 | 1995-10-03 | Ahluwalia; Gurpreet S. | Inhibition of hair growth |
Also Published As
Publication number | Publication date |
---|---|
FR1120M (en) | 1962-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES370058A1 (en) | Antibiotic compositions | |
GB967133A (en) | Improvements in or relating to anti-tubercular and anti-leprotic pharmaceutical compositions comprising isonicotinoyl hydrazine derivatives | |
ES410825A1 (en) | Quinoline derivatives | |
GB1004468A (en) | Chroman derivatives | |
GB939901A (en) | Improvements in or relating to amino pyrazoles | |
GB1264798A (en) | ||
GB1294299A (en) | Isoniazid derivative | |
ES264510A1 (en) | Improvements in or relating to pharmaceutical iron preparations | |
GB739800A (en) | Aqueous pharmaceutical solutions of reserpine for parenteral administration | |
GB972672A (en) | Pharmaceutical preparations containing compounds of the androstane series | |
ES395433A1 (en) | Stable aqueous pyritinol solutions | |
GB931921A (en) | Therapeutic compositions intended for the treatment of any hepatic malfunctionings | |
GB879155A (en) | New antimony derivatives | |
ES377725A1 (en) | Improvements in pharmaceutical compositions | |
ES333664A1 (en) | A procedure for the preparation of antibacterial agents. (Machine-translation by Google Translate, not legally binding) | |
GB950162A (en) | Medicines for the treatment of hepatic disorders | |
GB951732A (en) | Therapeutic composition having a blood cholesterol lowering action and containing nicotinic acid n-oxide | |
GB1020073A (en) | A salt of nicotinic acid | |
GB884576A (en) | Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof | |
GB967475A (en) | Improvements in or relating to pharmaceutical compositions comprising a salt of (n-methylene-sulphoxylate)-4-amino-2-hydroxybenzoic acid | |
GB870713A (en) | Kanamycin salts and therapeutic preparations containing the same | |
GB845454A (en) | Preparation of improved tetracycline antibiotic compositions | |
GB877464A (en) | Therapeutic anti-depressant compositions comprising hydrazine derivatives | |
GB908076A (en) | Fibrinolytic compositions suitable for buccal administration | |
GB840239A (en) | New anthelmintic compositions |